Efficacy And Safety Study Of Naftopidil to Patients Treatment With LUTS

NCT01203371 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Hyperplasia

Interventions

DRUG: Naftopidil
DRUG: Tamsulosin

Sponsor

Apsen Farmaceutica S.A.